Introduction
A variety of conditions are characterized by pain associated with sensitivity to touch, together with colour, temperature and trophic changes in the affected region of the body. In the past, these conditions have attracted a variety of names in English and other languages. Perhaps the most widely used term has been`re¯ex sympathetic dystrophy' (RSD), which re¯ected the prevailing belief that these conditions involved abnormal re¯ex activity in the sympathetic nervous system. A companion term`causalgia' was by convention reserved for those conditions caused by an injury to a major peripheral nerve.
At a conference held in 1993, experts interested in these conditions called for a revision and standardization of the nomenclature [1] . They believed that a single, well-de®ned term was preferable to a plethora of competing, ill-de®ned terms that were often used indiscriminately; but moreover, they believed that previous terms were inaccurate. Accumulated evidence had shown that these conditions did not necessarily involve re¯exes, nor were their features necessarily produced by sympathetic nerves. Accordingly, they recommended the term complex regional pain syndrome' (CRPS). The nomenclature was extended to include CRPS type II for those conditions caused by injury to a peripheral nerve, and CRPS type I for all other varieties. The proposed nomenclature was adopted by the International Association for the Study of Pain (IASP) [2].
Complex regional pain syndromes are dif®cult problems. Dif®culties pertain not only to its treatment but also to its diagnosis. Problems persist even as to their nomenclature.
Nomenclature
Despite being recommended by the IASP, the term CRPS' has not met with universal or even widespread acceptance throughout medicine at large. A survey of the literature published between 1995 and 1999 found that out of 900 articles on the topic, barely 11% used the new term [3]. However, the use of the term increased from 3.5% of articles in 1995 to 27% in 1999, with the use of RSD' decreasing by a complementary amount. In contrast, few authors used the term`CRPS type II', preferring to retain the former term`causalgia'.
Diagnostic criteria
A feature of the diagnostic criteria proposed by the IASP (Table 1) is that they allow options. The patient may have pain, allodynia, or hyperalgesia; they may have oedema, changes in blood¯ow, or abnormal sweating. For this reason several commentators have remarked that the criteria lack speci®city.
One group [4] found that the IASP criteria did not discriminate patients with CRPS from those with diabetic neuropathy. Depending on how stringently the criteria were applied, their positive predictive value ranged between only 40 and 60%. However, if the liberty for options was removed, and instead the possible features of CRPS were listed in a checklist and scored independently, diagnostic accuracy could be improved. A score of 11 or more on the authors' checklist (Table 2) provides a sensitivity of 0.71, a speci®city of 0.95, and a positive predictive value of 0.91. This same group led a later study [5] , which used principal components factor analysis to identify how clinical features might be assigned to clusters so that within each cluster the features had similar discriminating power, but different clusters had different and independent discriminating power. In essence, this approach provided clusters of diagnostic criteria that should be satis®ed, but options obtained within each cluster ( Table 3) .
The inclusion of motor features in these criteria (Tables  2 and 3) is an innovation, for these were not recognized as criteria by the IASP [2]. However, others have noted that motor features occur in a substantial proportion of patients with CRPS [6±8]. When present, they serve to discriminate CRPS from less complex, or purely sensory neuropathies.
Mechanisms
Experts [8] and reviewers [9] still wrestle with the pathophysiology of CRPS. In trying to explain the sensory abnormalities, they referred to experimental studies of nerve injury [8] , even though there is no evidence that CRPS type I involves any nerve injury. In explaining the autonomic features, they referred to some peripheral mechanisms, but largely they retreated tò central' mechanisms [8, 9] . Recent publications also emphasized central mechanisms, although without expressing exactly what they may be.
When subjected to quantitative sensory testing, patients exhibited normal thresholds for the detection of cold and heat, but their thresholds for cold-pain and heat-pain were reduced [10] . These patterns argue against a peripheral disorder of nociceptive afferents, and point more to a selective disturbance within the central nervous system.
Using Doppler¯uxmetry, one study [11] showed that patients who developed CRPS after a fracture of the radius exhibited an absent or diminished sympathetic vasoconstrictor response from the ®rst day after injury, even before any clinical features of CRPS were evident. A. The presence of an initiating noxious event or a cause of immobilization. B. Continuing pain, allodynia, or hyperalgesia with which the pain is disproportionate to any inciting event. C. Evidence at some time of oedema, changes in skin blood flow, or abnormal sudomotor activity in the region of pain. D. This diagnosis is precluded by the existence of conditions that would otherwise account for the degree of pain and dysfunction. The authors furthermore demonstrated that disturbances in the sympathetic nervous system were systemic and were not restricted to the affected limb. Others showed that in some patients symptoms of CRPS were not restricted to the affected limb, but could spread to the contralateral limb, or to remote limbs [12] . These patterns of spread can only be attributed to a disturbance of function in the central nervous system.
A detailed study of thermoregulation responses [13] showed that when challenged by whole-body cooling, patients with early CRPS showed less cooling in the affected limb, whereas those with long-standing CRPS showed greater cooling in the affected limb. Other patients exhibited a mixture of greater and lesser cooling across the range of temperatures to which the limbs were exposed. The investigators interpreted these differences to indicate that early CRPS involves the inhibition of cutaneous vasoconstrictor neurons, but chronic CRPS involves a competition between the continued inhibition of vasoconstriction and supersensitivity of the peripheral vessels to circulating noradrenaline.
The notion of a central mechanism is supported by the close similarity between the autonomic features of CRPS and those of autonomic failure after stroke [14] . The latter occur in the absence of pain, which suggests that the pain and sensory features of CRPS are caused by parallel but separate mechanisms from those that underlie the autonomic features. Moreover, the evidence from patients with stroke suggests that the autonomic features arise as a result of some form of disinhibition, rather than being elicited as a re¯ex.
Other investigators have focused on mechanisms in the periphery. One group [15] demonstrated that patients with CRPS exhibit increased extravasation of plasma proteins when cutaneous nerves are electrically stimulated in a retrograde fashion. They argued that this behaviour suggested the increased release of neuropeptides that sensitize cutaneous vessels. Furthermore, they entertained the possibility that these neuropeptides were in turn released in response to impaired blood ow, oxygen de®ciency in the affected tissues, and an increase in protons therein. Their other studies complemented this argument. They showed that whereas intravenous levels of lactic acid were normal in the affected limbs of patients with CRPS, skin lactate levels were increased [16] . Furthermore, experimental infusion of acidi®ed interstitial¯uid into the skin of these patients increased their pain [17 . ].
Other views
Not all authorities consider CRPS to be an organic syndrome. In letters to the editor [18] they argued that the neurological basis of CRPS has been overstated, and that proponents overlook the psychiatric dimensions of the condition; they implied that CRPS may be a somatoform pseudoneurological illness. In their own studies, they found that patients could be relieved of motor weakness and movement disorders by placebo blocks of peripheral nerves or placebo infusions [19 . ]. Accordingly, they argued that abnormal movements in CRPS I are of somatoform or malingerer origin, and provide a predictive signal of psychogenic dysfunction. At the very least, these observations warned that no deduction should be made about the result of diagnostic blocks or infusions unless they are subjected to placebo controls.
Assessment
Some investigators emphasized the utility of laboratory tests to provide objective measures of sudomotor and vasomotor function [7, 8] . These included the quantitative sudomotor axon re¯ex test, resting sweat output, and infrared thermometry. However, although having a positive laboratory test may seem to increase diagnostic con®dence, it has been shown that symptoms of CRPS correlate strongly with laboratory results [7, 20] . Therefore, the presence of symptoms already predicts that laboratory tests will be positive, and having positive results increases diagnostic con®dence only marginally [7] . On the other hand, laboratory tests are more useful when their results are negative, for in that event they serve to refute the diagnosis when clinical features are weak or minimal, thereby reducing the over-diagnosis of CRPS [7] .
False-positive symptoms are a particular problem in CRPS. Patients may report symptoms suggestive of vasomotor changes, but objective investigations may reveal no disturbance of vasomotor function. Similarly, physicians may infer that sympathetic function has been altered after sympathetic blockade, but in this regard, clinical assessment is capricious. When compared with the results of laboratory testing, physicians' judgements of sympathicolysis are imperfect. Clinical assessment correctly detects all patients whose sympathetic nerves have been successfully blocked, but some 50% of patients clinically judged to have sympathicolysis have intact sympathetic function when tested by laser Doppler¯owmetry [21] .
For testing sensory abnormalities, either a relative approach, comparing the affected side with the unaffected side, or an absolute approach can be used. When compared, the two approaches result in different ®ndings in 20% of cases [22] . In order to improve sensitivity in diagnosis, investigators have recommended the relative approach, when possible [22] .
Prevention
Of concern to surgeons is the risk of precipitating a recurrence of CRPS in patients with a past history of the disorder, who require surgery on the previously affected part. A controlled study [23 . ] found that the risk of CRPS can be reduced by performing a stellate ganglion block after the completion of surgery. An uncontrolled study reported that recurrence was prevented by perioperative calcitonin prophylaxis [24] .
A placebo-controlled study published in 1999 [25] reported that the prophylactic use of vitamin C could reduce the occurrence of CRPS in patients who suffered a fracture of the radius. More recently, this study attracted comment in the orthopaedic literature. Although the results were not disputed, the study was challenged for the lack of a rationale for the treatment, further studies were called for to corroborate the result [26 . . ]. The commentator seemed not to be aware of the growing literature on oxygen-free radicals in CRPS [15,16,17 . ].
Treatment
The treatment of CRPS has relied largely on traditional wisdom and expert advice. Many of the recommended interventions, however, have not been subjected to scienti®c scrutiny and, therefore, lack an evidence base. Therefore, whereas experts [6] and expert committees [27] recommended occupational therapy, vocational rehabilitation, physical therapy, behavioural therapy, and various drugs, the formal evidence of ef®cacy is either weak or lacking.
No more recent study has supplanted the systematic review of Kingery [28] . He found that the only trial data that consistently demonstrated analgesia was with oral corticosteroids; there was limited support for the analgesic effectiveness of topical dimethylsulphoxide, epidural clonidine, and intravenous infusions of bretylium and ketanserin. He found con¯icting results for the ef®cacy of intranasal calcitonin and for intravenous phentolamine. However, he found consistent evidence that intravenous guanethidine and reserpine were ineffective, as were droperidol and atropine. He found no controlled trials of the ef®cacy of physical therapy. The evidence for sympathetic blocks with local anaesthetic, as a form of treatment, was not compelling, local anaesthetic being no more effective than agents shown in other studies to be no more effective than placebos. Some developments, however, have occurred since that review.
Small, uncontrolled studies [29, 30] announced success in reducing pain using lamotrigine, subcutaneous infusions of lidocaine [31] , and continuous infusions of morphine onto the brachial plexus in the axilla [32] . Other authors have reiterated the apparent utility of continuous brachial plexus blocks [33] .
A variety of interventions have been subjected to controlled studies. One compared the ef®cacy of physiotherapy, occupational therapy, and a control therapy consisting of social work attention [34] . With respect to pain, no differences in outcome were detected between the three groups at 12 months. Signi®cant differences were detected in favour of physiotherapy and occupational therapy over social work, but only with respect to small improvements in temperature and the global impairment scale.
Because osteoporosis can be a feature of CRPS, rheumatologists have explored the ef®cacy of bisphosphonates as a treatment. One controlled study [35] showed that alendronate can improve bone mineral content in patients with CRPS. Pain and tenderness also seemed to be improved, but the differences were not signi®cantly greater than in the control group. Another study [36 . . ], however, showed that intravenous clodronate achieved substantial improvements in pain, sig-ni®cantly greater than placebo; and that patients achieved a reduction in mean pain scores from 61 at baseline to 4 at six months, on a 100-point scale.
Intrathecal baclofen has proved to be effective in reducing dystonias in patients with CRPS of the upper limb, but enigmatically not in those in whom the lower limb was affected [37] . There were no consistent effects, however, on pain or other symptoms.
Previously, spinal cord stimulation had been advocated as a treatment for CRPS, but only on the basis of descriptive studies [25] . Stronger evidence of ef®cacy has now appeared. In a randomized trial [38 . . ], the outcomes of patients treated with spinal cord stimulation and physical therapy were compared with those of patients treated with physical therapy alone. The combined treatment achieved signi®cantly greater improvements in pain, sustained at 1, 3, and 6 months after treatment. In a separate publication [39], the same investigators reported that the relief of pain was not contingent upon vasodilation having been achieved. However, the average improvement in pain was only from 7 to 4 on a 10-point visual analogue scale, and the changes in other measures of pain and measures of functional status and healthrelated quality of life did not differ between the treatment groups [38 . . ]. Consequently, although welcome in a ®eld largely devoid of evidence, that study left a quandary: are invasive and costly interventions justi®ed when they produce modest symptomatic relief but no other attributable bene®t for the patient?
Conclusion
CRPS remains a troublesome disorder. Some progress has been made to re®ne the diagnostic criteria so as to render the diagnosis more speci®c. The diagnosis can be made clinically using checklists that cluster features into separate categories of sensory, vasomotor, sudomotor, and motor/trophic changes. The pathophysiological mechanisms of the symptoms and signs still remain obscure, and some authorities maintain that they are psychogenic. Stellate ganglion blocks appear to be effective in reducing the recurrence of CRPS in patients needing to undergo surgery on a previously affected limb. Vitamin C appears to reduce the incidence of CRPS after fractures of the radius. Little progress has, however, occurred with respect to treatment. Most treatments that are advocated have not been tested in controlled trials or have been found to confer no bene®t greater than placebo. Physiotherapy offers little advantage over social work attention. Bisphosphonates appear to be promising both as a means of reducing pain and of reversing osteoporosis. Spinal cord stimulation has been proved to relieve pain but it does not improve function.
